FIELD: organic chemistry. SUBSTANCE: invention relates to a novel salt, namely, (R)-3-N, N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyrane- 5-carboxamide acid tartrate, in part, its (2R,3R)-tartrate and especially to (R)-3-N, N, -dicyclobutylamino- 8-fluoro-3,4-dihydro-2H-1-benzopyrane-5-carboxamide acid (2R,3R)-tartrate monohydrate. Invention relates also to method of synthesis of indicated tartrate salt and pharmaceutical composition based on thereof used for treatment and prophylaxis of central nervous system (CNS) disorders and corresponding impairments of medicinal nature associated with activity of antagonist of 5-HT1A-receptors. Invention provides the preparing the novel salt of (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1- benzopyrane-5-carboxamide showing good solubility with low degree of hygroscopicity that makes the preparation based on thereof to be more stable in prolonged storage and the most useful in terms of quality guarantee. EFFECT: improved method of synthesis and preparing, valuable medicinal properties of salt. 14 cl, 2 dwg _
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF 3-N,N-DICYCLOBUTYLAMINO-8- -FLUORO-3,4- DIHYDRO-2H-1-BENZOPYRANE-5-CARBOXAMIDE AS RACEMIC COMPOUND OR R- OR S-ENANTIOMERS AND INTERMEDIATE COMPOUNDS |
1998 |
- Khanson Sverker
- Jokhansson Lars
- Son Dehniehl D.
|
RU2192422C2 |
COMPOUNDS (R)-5-CARBAMOYL-8-FLUORO-3,N,N-DISUBSTITUTED AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OF PATIENTS AND METHODS OF SYNTHESIS OF COMPOUNDS |
1994 |
- Dzhon Lesli Ivenden
- Ehva Marija Khammarberg
- Khans Sverker Khansson
- Sven Ehrik Khell'Berg
- Lars Georg Iokhansson
- Jokhan Rune Mikhaehl' Lundkvist
- Svante Bertil' Ross
- Deniehl Dungan Son
- Set Olov Torberg
|
RU2142951C1 |
COMBINATION OF REUPTAKE INHIBITOR OF 5-HT WITH SELECTIVE 5-HT ANTAGONIST |
1996 |
- Ehvenden Dzhon
- Torberg Sent-Olov
|
RU2183955C2 |
CARBAMIC ACID AZABICYCLIC ESTERS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND INTERMEDIATE COMPOUNDS |
1997 |
|
RU2172739C2 |
COMBINATION OF SELECTIVE ANTAGONIST OF 5HT AND SELECTIVE ANTAGONIST OR PARTIAL AGONIST OF H5-HT |
1998 |
- Berg Stefan
- Ross Svante
- Torberg Set-Olov
|
RU2215528C2 |
BENZOPYRANS, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF MEDICAL TREATMENT |
1995 |
- Vaj Ngor Chan
- Ehlen Kejt Ehnn Morgan
- Mervin Tompson
- Dzhon Morris Ehvans
|
RU2147581C1 |
DERIVATIVES OF 1,2,3,4-TETRAHYDRONAPHTHALENE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT |
1998 |
- Berg Stefan
- Linderberg Mats
- Ross Svante
- Torberg Set-Olov
- Ul'Ff Bengt
|
RU2194696C2 |
S-ENANTIOMER OF SUBSTITUTED 2-AMINOTETRALINE, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING PROPERTY OF 5- RECEPTOR ANTAGONIST |
1990 |
- Uli Khaksell[Se]
- Sven-Ehrik Khillver[Se]
|
RU2086537C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT MACULAR DEGENERATION |
2012 |
- Yi Kyu-Yang
- Yoo Sung-Eun
- Kim Nack-Jeong
- Suh Jee-Hee
- Joo Choun-Ki
- Choi Jun-Sub
- Yang Jae-Sik
- Lee Geun-Hyeog
- Cho Yun-Seok
- Park Jin-Ha
- Lee Hye-Sung
|
RU2576380C2 |
BENZOPYRANS, METHOD OF PREPARATION THEREOF, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS |
1996 |
|
RU2160735C2 |